prikaz prve stranice dokumenta PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA
  Download
PDF 615.38 KB
undergraduate thesis
PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA
Rijeka: University of Rijeka, Faculty of Health Studies, 2021. urn:nbn:hr:184:226233
Višković, Patrik
University of Rijeka
Faculty of Health Studies
Department of Laboratory and Radiological Diagnostics

Cite this document

Višković, P. (2021). PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA (Undergraduate thesis). Rijeka: University of Rijeka, Faculty of Health Studies. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:226233

Višković, Patrik. "PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA." Undergraduate thesis, University of Rijeka, Faculty of Health Studies, 2021. https://urn.nsk.hr/urn:nbn:hr:184:226233

Višković, Patrik. "PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA." Undergraduate thesis, University of Rijeka, Faculty of Health Studies, 2021. https://urn.nsk.hr/urn:nbn:hr:184:226233

Višković, P. (2021). 'PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA', Undergraduate thesis, University of Rijeka, Faculty of Health Studies, accessed 24 April 2024, https://urn.nsk.hr/urn:nbn:hr:184:226233

Višković P. PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA [Undergraduate thesis]. Rijeka: University of Rijeka, Faculty of Health Studies; 2021 [cited 2024 April 24] Available at: https://urn.nsk.hr/urn:nbn:hr:184:226233

P. Višković, "PROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA", Undergraduate thesis, University of Rijeka, Faculty of Health Studies, Rijeka, 2021. Available at: https://urn.nsk.hr/urn:nbn:hr:184:226233

Please login to the repository to save this object to your list.
Metadata
TitlePROGNOSTIČKI ČIMBENICI U LIJEČENJU KARCINOMA DOJKE U MUŠKARACA
Title (english)PROGNOSTIC FACTORS IN THE TREATMENT OF BREAST CANCER IN MEN
AuthorPatrik Višković
MentorFranjo Lovasić (mentor)
Committee memberHarry Grbas (predsjednik povjerenstva)
Committee memberManuela Avirović (član povjerenstva)
Committee memberNeva Girotto (član povjerenstva)
GranterUniversity of Rijeka
Faculty of Health Studies
(Department of Laboratory and Radiological Diagnostics)
Rijeka
Defense date and country2021-07-02, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract
Poznato je kako je rak dojke jedan od najčešćih zloćudnih tumora u žena. Čini gotovo 25% tumora u žena i uzrokuje oko 15% smrti zbog raka. U muškaraca je rak muške dojke rijetka bolest koja čini svega 0, 1% ukupnog broja karcinoma u muškaraca. Najveća incidencija tog malignoma jest u starijoj životnoj dobi od oko 70 godina. Najvažniji poznati rizični čimbenici pri nastanku raka muške dojke jesu dob, genetska predispozicija, rasa, izloženost djelovanju estrogena i vanjski čimbenici okoline. Nažalost malignom muške dojke najčešće se otkriva u kasnijem stadiju bolesti nego u žena. Kad je riječ o liječenju raka dojke u muškaraca, tada možemo reći kako se koriste iste metode kao i kod liječenja karcinoma dojke u žena. Nakon postavljanja dijagnoze, ovisno o stadiju bolesti i podtipu invazivnog karcinoma, određuje se način liječenja. Prognoza bolesti i preživljenje bolesnika uvelike ovisi o stadiju dijagnosticiranja same bolesti, što znači da otkrivanje karcinoma u ranom stadiju bolesti osigurava veću mogućnost izlječenja kao i samog oporavka bolesnika, u usporedbi s uznapredovalim ili metastatskim karcinomom dojke.
Abstract (english)
Breast cancer is known to be the second most common malignancy, and by far the most common tumor in women. It makes up almost 25% of tumors in women and causes about 15% of cancer deaths. However, the situation is quite different in men, because if it is male breast cancer, it is then a rare disease that accounts for only 0.1% of the total number of cancers in men. The highest incidence of this malignancy is in the older age of about 70 years. The most important known risk factors for the development of male breast cancer are age, genetic predisposition, race, estrogen exposure and external environmental factors. Unfortunately, male breast malignancy is most often detected at a later stage of the disease than in women. When it comes to treating breast cancer in men, then we can say that the same methods are used as in the treatment of breast cancer in women. After establishing an accurate diagnosis, including an assessment of the affected areas, the method is prescribed, as well as the treatment itself. The prognosis of patient survival largely depends on the stage of diagnosing the disease itself, which means earlier detection ensures a greater possibility of cure as well as the patient's recovery.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:184:226233
Study programmeTitle: Radiological Technology
Study programme type: professional
Study level: undergraduate
Academic / professional title: stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) radiološke tehnologije (stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) radiološke tehnologije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
RepositoryRepository of the University of Rijeka, Faculty of Health Studies
Created on2021-08-27 08:45:26

(©) Nacionalna i sveučilišna knjižnica u Zagrebu 2015. Sva prava pridržana. | Hrvatske bratske zajednice 4 p.p. 550, 10000 Zagreb, Hrvatska Tel. ++ 385 1 616-4040
OIB: 84838770814 | IBAN: HR66 2340 0091 1000 1008 1, Porezni broj (PDV identifikacijski broj) - VAT Number: HR84838770814
Prijava u repozitorij